Adaptive Biotechnologies Corp — Director's Dealing 2025

Mar 7, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2025-03-04

Reporting Person: Pellini Michael J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-04	Common Stock	A	15394	—	Acquired	69690	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-04	Stock Option (right to buy)	$8.12	A	23726	Acquired	2035-03-04	Common Stock (23726)	Direct

Footnotes

F1: The option will vest in equal monthly installments over one year from March 4, 2025, subject to continued service as a director through such vesting dates.